Sidekick in the news

Sidekick Health is tackling the medication adherence problem head-on with an innovative, integrated approach for US payers: combining brand-specific medication adherence layers, developed with global pharmaceutical partners, with Sidekick's digital-first, multi-condition care platform designed to deliver seamless, personalized, and scalable support with the goal to improve adherence — and cuts costs.

Ypsomed and Sidekick Health are launching an integrated digital health solution to better support people with obesity. Ypsomed's autoinjectors seamlessly integrate into Sidekick's digital health and chronic condition support app to help patients using GLP-1-based injectable therapies manage their treatment more effectively.

Sidekick Health, a leading digital health company, today announced the launch of a clinical study of its latest prescription digital therapeutic (PDT), MENO! App, designed to address the unmet needs of women experiencing menopause. Sidekick is initiating a 12-week clinical study in Germany to further validate the MENO! App's impact on menopause symptom relief.

In an article published on Business Reporter, Dr Tryggvi Thorgeirsson, Co-Founder and CEO of Sidekick Health talks about the role digital tools can play in shifting patients’ attitudes from passive consumption of health advice to active participation in their health and lasting behavioural change.

Sidekick Health, a global leader in digital health innovation, today announced the acquisition of PINK!, a pioneering digital health company specializing in cancer support and women's health. This strategic move enhances Sidekick Health's portfolio and strengthens its position in the digital therapeutics market.

Imagine a digital health solution accessible via smartphones that empowers individuals to self-manage their health conditions and make informed, positive choices. In this episode of the Outcomes Rocket podcast, Dr. Tryggvi Thorgeirsson, the CEO of Sidekick Health, dives deep into their work, a digital health solution that aims to empower patients with chronic conditions to manage their health effectively.

Íslenska heilbrigðistæknifyrirtækið Sidekick Health hefur gengið frá kaupum á þýska fyrirtækinu aidhere GmbH, sem hefur verið leiðandi í lyfseðilskyldum heilbrigðistæknilausnum.

Sidekick Health's CEO, Dr. Tryggvi Thorgeirsson, shared that the decision to acquire aidhere was fueled by the shared PDT vision and cultural alignment of the two organizations. "Developing and distributing prescribed therapeutics has always been core to our long-term vision, and when we were introduced to aidhere's remarkable products and exceptional team, we knew that joining forces was the right step to take," said Thorgeirsson.

Das in Reykjavik (Island) ansässige Unternehmen Sidekick Health, ein globaler Anbieter digitaler Therapeutika, hat das Digital Health-Unternehmen aidhere mit Sitz in Hamburg und Leipzig übernommen. Mit dieser Akquisition erweitert Sidekick sein Produktportfolio und betritt den Markt verschreibungspflichtiger Therapeutika. Die digitale Gesundheitsanwendung (DiGA) zanadio von aidhere bleibt weiterhin verordnungsfähig und uneingeschränkt nutzbar. Zudem sind weitere neue DiGA in Planung.

Íslenska heilbrigðistæknifyrirtækið Sidekick Health hefur gengið frá kaupum á þýska fyrirtækinu aidhere GmbH.

In a significant move that underscores Sidekick Health’s commitment to furthering the impact of digital healthcare, the company is thrilled to announce its expansion into the direct prescribing space working collaboratively with healthcare providers.

Íslenska heil­brigðis­tæknifyr­ir­tækið Si­dekick Health hef­ur gengið frá kaup­um á þýska fyr­ir­tæk­inu aidh­ere GmbH. Kaup­in styrkja enn frek­ar vöru­fram­boð Si­dekick Health og renna þriðju grunnstoðinni und­ir rekst­ur fyr­ir­tæk­is­ins.

Icelandic digital health company Sidekick Health is acquiring German prescription digital therapeutics (PDT) company aidhere in a strategic move that places the business directly into the digital prescription space. PDTs are an emerging technology area that are expected to exponentially grow in the future as clinicians look for solutions to support chronic disease management. The software-based treatments are highly regulated and delivered on mobile devices that address the behavioral dimensions of several diseases and conditions.

Sidekick Health, a global leader in digital health innovation, is poised to transform the landscape of digital therapeutics with the strategic acquisition of aidhere, a leading developer of prescription digital therapeutics (PDT) based in Germany.

The acquisition of aidhere strengthens Sidekick Health's digital health offering to patients and partners with the world's leading PDT company.

Through apps, pharmaceutical companies can actually influence patient adherence and mindset after that patient has been prescribed that company's medication by their physician.

The combination of Ypsomed’s devices with Sidekick’s digital health, behavioural economics and gamification expertise will form a unique solution delivering an engaging and personalised patient experience to people with chronic conditions, as well as a turn-key, best-in-class digital therapy management system for pharmaceutical customers.

The combination of Ypsomed’s devices with Sidekick’s digital health, behavioural economics and gamification expertise will form a unique solution delivering an engaging and personalized patient experience to people with chronic conditions, as well as a turn-key, best-in-class digital therapy management system for pharmaceutical customers.

Emerging digital therapeutics company Sidekick Health has partnered with Ypsomed, the Swiss group best known for its insulin delivery systems, to co-develop software designed to improve patient’s experience self-medicating with injectors and ultimately improving adherence and outcomes.

Asking patients with chronic conditions to regularly inject themselves can be challenging, causing needle anxiety and worry that they may not carry out the procedure correctly, which can reduce compliance. Now, a partnership between Ypsomed and Sidekick Heath aims to tackle that problem.

Galvanised by pandemic-driven digitalisation, increasingly favourable regulation and record amounts of VC money flying around, investor interest in startups reshaping the way patients access healthcare boomed.

Sidekick Health is already working with pharma heavyweights Pfizer and Bayer on gamified apps that can be paired with drug therapies to improve patient outcomes – and says it is poised to announce three more in the coming months.

Digital therapeutics plus pills? Iceland's Sidekick Health has developed a gamified digital care platform that's designed to support healthcare outcomes by applying personalized behavioral lifestyle nudges, including alongside clinical treatments like drugs, to augment, extend and support patient care for a range of chronic diseases and conditions from cancer to cardiovascular health, diabetes and arthritis -- a formula that's now scored it $55 million in Series B growth funding.

Pharmaceutical company Eli Lilly, in collaboration with Sidekick Health, is launching an online platform for breast cancer patients in Germany. The app will give patients specific diet plans, physical activity regimens and tools for sticking to their medication as well as suggestions for sleep and stress management. The goal is to see whether behavioral changes in tandem with medication can improve outcomes.

Shocked by the high dropout rates among users of digitally delivered lifestyle-change programs, the Icelandic physician Tryggvi Thorgeirsson realized that the apps left people with an unmet need: fun. The programs had been designed to appeal exclusively to the rational side of the brain; their developers had assumed that the life-threatening nature of participants’ conditions would be motivation enough.

The pharmaceutical firm will work with the health tech company to create a digital therapeutic intended for patients dealing with a breast cancer diagnosis.

Digital therapeutics firm Sidekick Health has joined forces with pharma giant Pfizer to launch a digital therapeutics solution for Atopic Dermatitis (AD). We briefly introduced their solution on our Patreon page, you will find the interview with co-founder Sam Oddsson here.

Eli Lilly has joined forces with the digital therapeutics developer Sidekick Health to offer tailored apps that help patients with breast cancer stick to their medication regimens. The duo also said they plan to expand their work into other disease and treatment areas.

Eli Lilly has inked a partnership with Iceland-based Sidekick Health to provide a companion digital health application that would be used along with the drugmaker's breast cancer treatments. The digital therapeutic, which is designed to be used on a smartphone, is intended to provide behavior modifications.

In May, Sidekick Health AB revealed an expanded partnership with New York-based Pfizer Inc. for autoimmune-related conditions. Now, it has joined forces with Eli Lilly and Co. to help patients battling breast cancer with its gamified platform. The companies plan to introduce the integrated digital therapeutic starting in July with the roll out beginning in Germany.

Through Sidekick’s platform, patients will be given access to a tailored digital treatment plan to promote behaviour modification and overcome barriers to change. Patients will also be able to access educational content on living with cancer. The integrated DTx offering will be initially rolled out in Germany from July.

A personalised, treatment plan for patients with breast cancer is the first digital health product to emerge from a newly-announced partnership between digital health specialist Sidekick and pharma group Eli Lilly. The two companies say the integrated digital therapeutic (DTx) for breast cancer will aim to promote behaviour modifications to improve the wellbeing of breast cancer patients as well as adherence to drug treatment, foe example by managing side effects.

Sidekick Health announced on Thursday that it entered into a strategic collaboration with Eli Lilly on an integrated digital therapeutics (DTx) solution for patients with breast cancer. Sidekick's DTx platform, which offers patients a tailored digital treatment plan that promotes behaviour modification and improves medication adherence, will initially launch in Germany.

A tiny startup just won a crucial deal with $175 billion drug giant Pfizer, and it shows how apps are becoming the next frontier as Big Pharma pushes beyond pills

A long-running partnership between digital therapeutics (DTx) developer Sidekick Health and Pfizer has resulted in a new app to support patients with atopic dermatitis, which will start rolling out in Europe and Japan later this year.

Sidekick Health AB expanded its partnership with Pfizer Inc., adding an atopic dermatitis offering to its integrated digital therapeutics solution. The app will roll out first in the U.K., followed by Belgium, Norway, Netherlands, Sweden, France, Ireland and Japan this year.

Sidekick Health, an Iceland-based developer of digital therapeutics, and Pfizer will launch an integrated digital therapeutic to aid those with atopic dermatitis this year. The digital therapeutic is set to launch in the U.K. first, followed by Belgium, Norway, the Netherlands, Sweden, France, Ireland, and Japan later this year.

Big Pharma has been slowly but surely warming up to the potential of digital therapeutics, as evidenced by Sanofi inking a deal two months ago with DarioHealth. And on Thursday, another Big Pharma will take a look at the space in what it deems as simply the next step in an ongoing partnership.

Big Pharma has been slowly but surely warming up to the potential of digital therapeutics, as evidenced by Sanofi inking a deal two months ago with DarioHealth. And on Thursday, another Big Pharma will take a look at the space in what it deems as simply the next step in an ongoing partnership.

Digital therapeutics firm, Sidekick Health has joined forces with pharma giant Pfizer to launch an integrated digital therapeutics solution for Atopic Dermatitis (AD). The solution will be rolled-out in the UK first, followed by Belgium, Norway, the Netherlands, Sweden, France, Ireland, and Japan later this year.

As a part of the multimillion-dollar partnership, Sidekick and Pfizer will roll out their integrated digital therapeutics offering that will be launched first in the UK. It will be followed by Belgium, Norway, the Netherlands, Sweden, France, Ireland, and Japan later this year. This marks the next phase of a growing relationship to develop digital patient support programs globally, including expansion into 24 markets by 2024.

International digital therapeutics leader Sidekick Health today announces that it has raised $55 million in Series B funding. The round was led by London-based venture capital firm Novator Ventures, with additional participation from Wellington Partners, Asabys Partners, and Frumtak Ventures, as well as a US-based strategic investor that will be revealed at a later stage.

Hello Heart, a digital therapeutics company that focuses on heart health, raised $70 million in Series D funding. Growth equity firm Stripes led the round. Hello Heart said it will use the funding to further research and develop AI use cases for heart health. Its flagship product is a blood pressure monitor coupled with an app that has been cleared by the U.S. Food and Drug Administration. The company said it has doubled its employer client base in the last few months.

Novator Ventures has led a $55 million Series B for Sidekick Health. The startup has built a gamified digital care platform to help users manage and prevent chronic and lifestyle-related diseases. Sidekick raised a €17.5 million round in 2020.

Sidekick Health AB stepped into a leading role in the fast-growing digital health space with the closing of a $55 million series B this week and an ever larger number of partners for its gamified app. Designed to help better manage multiple chronic conditions, the digital therapeutic engages users in video game-like activities and rewards positive changes in lifestyle choices while delivering personalized educational components.

Digital therapy company Sidekick Health has raised $55 million in Series B funding to help it expand its business. The round was led by London-based venture capital firm Novator Ventures, with additional participation from Wellington Partners, Asabys Partners, and Frumtak Ventures, as well as a US-based strategic investor.

International digital therapeutics leader Sidekick Health has raised $55 million in a Series B funding round led by London-based venture capital firm Novator Ventures. Wellington Partners, Asabys Partners, and Frumtak Ventures also participated in the round along with a US-based strategic investor that will be revealed at a later stage.

The next generation of therapeutics designed to prevent, treat and help people manage a wide range of medical disorders, digital therapeutics is the way forward. Betting big on the segment, Icelandic digital therapeutics platform Sidekick Health has raised $55 million in Series B funding.

Icelandic digital therapeutics company Sidekick Health has raised $55 million in Series B funding to expand the range of chronic conditions it can help treat as well as to grow its commercial footprint in the U.S. The investment was led by London-based venture capital firm Novator Ventures with Wellington Partners, Asabys Partners, and Frumtak Ventures also taking part, the company said in a statement on Thursday. It plans to disclose the identity of a further U.S.-based investor at a later stage.

Digital therapeutics plus pills? Iceland’s Sidekick Health has developed a gamified digital care platform that’s designed to support healthcare outcomes by applying personalized behavioral lifestyle nudges, including alongside clinical treatments like drugs, to augment, extend and support patient care for a range of chronic diseases and conditions from cancer to cardiovascular health, diabetes and arthritis — a formula that’s now scored it $55 million in Series B growth funding.

Digital therapeutics (DTx) firm Sidekick Health today announced a raise of $55 million (€52M) in Series B funding. The round was led by London-based venture capital firm Novator Ventures, with additional participation from Wellington Partners, Asabys Partners, and Frumtak Ventures, and a US-based strategic investor that will be revealed at a later stage.

International digital therapeutics leader Sidekick Health today announces that it has raised $55 million in Series B funding. The round was led by London-based venture capital firm Novator Ventures, with additional participation from Wellington Partners, Asabys Partners, and Frumtak Ventures, as well as a US-based strategic investor that will be revealed at a later stage.

The round was led by Novator Ventures, with participation from Wellington Partners, Asabys Partners, and Frumtak Ventures, as well as a US-based strategic investor that will be revealed at a later stage. Novator Ventures general partner and founder Birgir Mar Ragnarsson joined Sidekick’s board of directors in conjunction with the closing of the Series B financing.

Looking to no longer play second fiddle, digital therapeutics developer Sidekick Health has set its sights on expanding its video-game-like platform to assist in treating people with multiple chronic conditions. After collecting $20 million in late 2020, the Swedish company now has another $55 million in venture capital for its efforts and has outlined plans to build out its commercial footprint in the U.S.

Digital therapeutics plus pills? Iceland’s Sidekick Health has developed a gamified digital care platform that’s designed to support healthcare outcomes by applying personalized behavioral lifestyle nudges, including alongside clinical treatments like drugs, to augment, extend and support patient care for a range of chronic diseases and conditions from cancer to cardiovascular health, diabetes and arthritis — a formula that’s now scored it $55 million in Series B growth funding.

Anthem piloting new COVID-19 recovery tool. The pilot is designed in partnership with Sidekick Health. Anthem has teamed with the tech startup on other concierge pilots, such as one for members with Crohn’s disease. While the COVID-19 program launched earlier this week, response to the Crohn’s disease platform has been positive.

DTx leader Sidekick announces key C-level hires in move to accelerate U.S. market growth. UnitedHealth Group and Anthem veteran Pamela Stahl joins as Chief Commercial Officer (CCO) and President, North America to lead Sidekick’s global commercial strategy, driving revenue growth with international pharmaceutical majors and U.S.-based payers. Mitchell Mudra joins Sidekick from UnitedHealth Group as Chief Operating Officer (COO), scaling the company’s operations and user volumes in close collaboration with its pharmaceutical and payer partners in the U.S. and beyond.

With so many health issues stemming from lifestyle-related illnesses, it’s no surprise that one of the biggest aspects of the modern lifestyle may be part of the cure. Sidekick Health uses digital therapeutics (DTx), behavioral economics combined with artificial intelligence and gamification elements such as charity rewards to help patients adapt their behavior and stick to medical treatment plans—all on their smartphones.

Disruptive Seasons – Winter 2021 Live Event. Oli Viggosson, CPO, shares insights about Sidekick’s story so far.

The Digital Health 150: The Top Digital Health Companies Of 2021. The Digital Health 150 is CB Insights’ annual ranking of the 150 most promising digital health startups in the world. This year’s winning companies include startups working on data integration & analytics, home health tech, virtual care, clinical intelligence, and more.

Dr Tryggvi Thorgeirsson of Sidekick Health: 5 Things I Wish Someone Told Me When I First Became A Doctor. As part of my series about healthcare leaders, I had the pleasure of interviewing Dr. Tryggvi Thorgeirsson, CEO and co-founder of Sidekick Health, the digital therapeutics (DTx) innovator delivering clinical treatments through technology to people with chronic illnesses, to improve care and health outcomes.

As pharmaphorum’s founder, Dr Paul Tunnah, continues his Health Innovators video series, he connects with the co-founder of Iceland’s Sidekick Health, Saemundur “Sam” Oddsson.

Oli Viggosson is a seasoned software architect from the gaming industry, previously holding senior management positions at gaming group CCP, the creator of the world’s largest multiplayer game EVE Online. He co-founded software development company Eskill in1999, which later merged with Nordic information technology leader Advania. He now leads product development as CPTO at Sidekick Health, a leader in digital health therapeutics for chronic disease management and treatment.

Sidekick Health presented research at the European Crohn’s and Colitis Organisation (ECCO) congress suggesting that its digital therapeutic platform provides a “feasible and possibly an effective way” of improving disease management among patients with ulcerative colitis. In a separate study, the company said a support programme offered through its platform for patients with inflammatory bowel disease (IBD) led to better patient-reported stress and energy levels in a real-world setting.

In this episode of the McKinsey on Startups podcast, Daniel Eisenberg speaks with Dr. Tryggvi Thorgeirsson, the CEO and Co-founder of Sidekick Health, an Iceland-based startup that works with pharmaceutical companies and insurers to provide gamified, digital care and therapeutic programs to help patients with disease management and treatments. An edited transcript of their conversation follows.

Sidekick Health aims to reduce healthcare strain and nudge people towards lasting lifestyle and behaviour changes with its digital therapeutics platform.

The Nordic startups and scaleups to watch in 2021. Our team of experts at Sifted have selected more than 100 companies we think you need to know about. Sidekick Health is one of a growing number of ‘digital therapeutics’ companies using apps to help people with lifestyle-related diseases.

Wellington Partners and Asabys Partners led the investment, which included participation from Novator and Frumtak Ventures. Regina Hodits of Wellington and Josep LI. Sanfeliu of Asabys will join the board.

SidekickHealth has now raised a total of $29.6M in total equity funding and this round was backed by investors that include Asabys Partners, Frumtak Ventures, Novator, and Wellington Partners.

Therapeutic game developer SidekickHealth raises $20M in series A round

La empresa nórdica de terapias digitales Sidekick Health ha completado una ronda de financiación de la Serie A con un exceso de suscripción de 20 millones de dólares liderada por Wellington Partners y Asabys Partners, a través de su fondo SAHII, con la participación de los inversores ya existentes, Novator y Frumtak Ventures.

Die Pharmaindustrie denkt über die Pille hinaus

Sidekick Health, a startup that has built a gamified digital care platform to help users manage and prevent chronic and lifestyle-related diseases, has raised a $20 million Series A. Wellington Partners and Asabys Partners led the round, which will be used for product development and expanding Sidekick's US operations.

Vitalis-stipendiet 2020 gick till Måns Lööf från Region Gävleborg som utvecklat en app som effektiviserat den psykiatriska vården. eHealth Award 2020 gick till scale up-företaget SidekickHealth för ett mobilt livsstilsspel som just nu gör succé världen över.

Sidekick Health has completed a $20 million (£15.3m) oversubscribed Series A financing round led by Wellington Partners and Asabys Partners, through its fund SAHII, with participation by existing investors Novator and Frumtak Ventures. The Nordic firm’s fundraising efforts were supported by the EIT Digital Accelerator, a European digital innovation initiative which supports startup and scale-up companies.

Gamified digital therapeutics firm Sidekick Health has raised $20 million in a Series A funding round, which it plans to use to develop its product offering. Based in Iceland, Sidekick said the oversubscribed funding round was led by Wellington Partners and Asabys Partners through its SAHII fund, with existing investors Novator and Frumtak Ventures.

The round was led by Wellington Partners and Asabys Partners, through its fund SAHII, with participation from existing investors Novator and Frumtak Ventures. In conjunction with the funding, Dr. Regina Hodits, managing partner at Wellington, and Josep LI. Sanfeliu, managing partner and co-founder of Asabys, will join the board of directors of Sidekick on behalf of the new investors.

Nordic digital therapeutics company, Sidekick Health, has closed a $20 million Series A led by pan-European VC Wellington Partners and healthcare focused VC Asabys Partners. Existing investors, Novator and Frumtak Ventures, also participated in the oversubscribed round.

Íslenska heilbrigðistæknifyrirtækið Sidekick Health fékk nýverið tæplega þriggja milljarða króna fjármögnun frá stórum erlendum sjóðum. Fyrirtækið stefnir á að þrefalda starfsmannahópinn á allra næstu misserum. Forstjórinn segir að þörf fyrir fjarheilbrigðiskerfi sé enn meiri nú þegar heimsfaraldur geisar.

Healthtech gamification platform Sidekick Health has landed $20 million in funding led by Wellington Partners and Asabys Partners. The startup's product helps manage chronic and lifestyle diseases “via digital nudges from a helmet-wearing cartoon helper,” TechCrunch reports.

Tech for Good. Sidekick Health raises $20m for gamified digital therapeutics

Heil­brigðis­tæknifyr­ir­tækið Si­dekick Health hef­ur tryggt sér nýtt fjár­magn að fjár­hæð 20 millj­ón­ir doll­ara. Er fjár­magn­inu ætlað að styðja við vöxt fyr­ir­tæk­is­ins í Evr­ópu og Banda­ríkj­un­um.

Sidekick, compañía Nórdica de terapias digitales, ha cerrado una ronda de financiación Series A de $20 millones liderada por la firma de capital riesgo (venture capital) Asabys Partners (desde su vehículo Sabadell Asabys Health Innovation Investments) y Wellington Partners, con la participación de inversores históricos de la compañía como Novator y Frumtak Ventures.

Sidekick Health, a nordic digital therapeutics company has completed a $20 million oversubscribed Series A financing round led by Wellington Partners and Asabys Partners, through its fund SAHII, with participation by existing investors Novator and Frumtak Ventures. Sidekick Health specializes in the creation of gamified digital therapeutic solutions and programs, transforming chronic and lifestyle disease management across multiple therapeutic areas, ranging from diabetes to ulcerative colitis and smoking cessation.

Sidekick, compañía Nórdica de terapias digitales, ha cerrado una ronda de financiación Series A de $20 millones liderada por Asabys Partners (desde su vehículo Sabadell Asabys Health Innovation Investments) y Wellington Partners, con la participación de inversores históricos de la compañía como Novator y Frumtak Ventures.

The Icelandic healthtech startup Sidekick Health has raised $20m in fresh funds from venture capital firms Wellington Partners and Asabys Partners.

Íslenska heilbrigðistæknifyrirtækið Sidekick Health hefur tryggt sér 20 milljón Bandaríkjadala fjármögnun, sem samsvarar um 2,8 milljörðum íslenskra króna, til þess að styðja við vöxt félagsins í Evrópu og Bandaríkjunum.

Sidekick opera una plataforma de salud digital que permite desarrollar programas terapéuticos para tratar múltiples patologías. La compañía ha cerrado acuerdos con compañías farmacéuticas, aseguradoras y proveedores de salud líderes a nivel internacional.

Asabys logra su particular sextete desde el estallido del Covid-19 en España. Sidekick, compañía nórdica de terapias digitales, ha cerrado una ronda de financiación de veinte millones de dólares liderada por Asabys Partners (desde su vehículo Sabadell Asabys Health Innovation Investments) y Wellington Partners, con la participación de los inversores actuales Novator y Frumtak Ventures, según han confirmado desde la compañía a PlantaDoce.

Nordic digital therapeutics company Sidekick Health has completed a $20 million oversubscribed Series A financing round led by Wellington Partners and Asabys Partners, through its fund SAHII, with participation by existing investors Novator and Frumtak Ventures.

Sidekick, a digital therapeutics scaleup supported by the EIT Digital Accelerator, raises $20M in Series A funding

The healthcare industry is still reeling under the massive blow dealt by the COVID-19 pandemic. One subset of the healthcare sector that has witnessed increased adoption in many countries during the lockdown. The reason behind its increased adoption seems to be that it helps people in ways that are cost-effective and compliant with social-distancing guidelines.

Sérhæfðir vísisjóðir fjárfestu í heilbrigðistæknifyrirtækinu. Novator og Frumtak Ventures tóku þátt í fjármögnuninni. COVID-19 gerði það að verkum að fjarheilbrigðisþjónusta fór að vaxa en hraðar en áður. Stór hluti af uppbyggingunni mun fara fram á Íslandi.

Pfizer acaba de cerrar un acuerdo con la empresa de salud digital SidekickHealth, que utiliza una aplicación móvil para ayudar a los pacientes a comer mejor, dormir mejor y tomarse sus medicinas cuando toca.

Nordic digital therapeutics company SidekickHealth announced a deal with Pfizer to launch a disease management platform in Europe in its second collaboration with the pharma giant unveiled in less than a year. Financial terms were not disclosed.

A tiny startup just won a crucial deal with $175 billion drug giant Pfizer, and it shows how apps are becoming the next frontier as Big Pharma pushes beyond pills Pfizer just cut a deal with the digital-health startup SidekickHealth, which uses a mobile app to help patients eat better, sleep better, and stick to their medications. The deal is worth more than $8 million, a person close to the transaction said. Sidekick's app is designed to help people manage their chronic conditions and improve their health.

Pfizer has linked with Nordic group SidekickHealth to launch a digital therapeutics platform designed to empower patients to take more control of their own health and boost wellbeing across Europe.